New Machine Learning-Based Test Could Improve Detection of Synthetic Cannabinoids
Association for Diagnostic and Laboratory Medicine (ADLM (formerly AACC))A novel study published today in AACC’s Clinical Chemistry journal shows that a machine learning-based test detects emerging synthetic cannabinoids with greater ease than standard methods. By making it simpler to identify new synthetic cannabinoids, this innovative screening test could significantly improve the ability of health professionals and lawmakers to protect the public from these potentially dangerous designer drugs.